Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study
Authors:
- 14 December 2020
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e928826
Abstract
Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study - Article abstract #928826Keywords
This publication has 25 references indexed in Scilit:
- Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcomeInternational Journal of Cancer, 2020
- Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial CarcinomaJournal of Pathology and Translational Medicine, 2019
- Cancer Antigen 125 Levels are Significantly Associated With Prognostic Parameters in Uterine Papillary Serous CarcinomaInternational Journal of Gynecological Cancer, 2018
- Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patientsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2018
- Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trialEuropean Journal of Cancer, 2013
- Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial CarcinomaClinical Cancer Research, 2013
- Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinomaJournal of Obstetrics and Gynaecology Research, 2011
- Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center studyGynecologic Oncology, 2010
- Feasibility of ovarian preservation in patients with early stage endometrial carcinomaGynecologic Oncology, 2007
- Survival patterns after oophorectomy in premenopausal women: a population-based cohort studyThe Lancet Oncology, 2006